Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure
- 1 February 2003
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 145 (2) , S26-S33
- https://doi.org/10.1067/mhj.2003.151
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Measurement and treatment of dyspnoeaRespiratory Medicine, 2001
- Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart FailureCirculation, 2000
- Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart FailureNew England Journal of Medicine, 2000
- VALIDATION OF THE UCSD SHORTNESS OF BREATH QUESTIONNAIREJournal of Cardiopulmonary Rehabilitation, 1994
- Measurement of dyspnoea in chronic obstructive pulmonary diseaseQuality of Life Research, 1993
- Measurement of Respiratory Sensation in Interstitial Lung DiseaseChest, 1989
- A comparison of Likert and visual analogue scales for measuring change in functionJournal of Chronic Diseases, 1987
- The Measurement of DyspneaChest, 1984
- Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.BMJ, 1978
- Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working PopulationBMJ, 1959